Register for #ASGCTBreakthroughs24 to learn about the latest advancements in CGT for muscular dystrophy! Join us Nov. 19-20 in Chicago or virtually.
The webinars in this series are designed to inform patients, patient advocates, families, and the public about various aspects of gene therapy.
The second in a series of five educational webinars from ASGCT and the National Organization for Rare Disorders (NORD), is now available to watch for free.
This session, held on Sept. 25, explored how gene therapies are developed, the ways in which evidence-based science guides manufacturers of gene therapies, how vectors deliver gene therapies to cells, and what happens inside the body after gene therapy is delivered. Speakers include Sven Kili, M.D., a member of the ASGCT Outreach and Communications Committee and a strategic consultant for regenerative medicine companies, and Tiffany Lucas, Ph.D., an FDA product reviewer in the division of gene therapy in the Center for Biologics Evaluation and Research (CBER).
Mark your calendar for the rest of the sessions in this free webinar series. All the webinars are designed to inform patients, patient advocates, families, and the public about various aspects of gene therapy.
The first webinar, “Gene Therapy: Yesterday, Today and Tomorrow,” is available for free here.
“Gene Therapy: Yesterday, Today, and Tomorrow,” the first of five educational webinars from ASGCT and the National Organization for Rare Disorders (NORD), is now available for free.
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico